OTUD7B upregulation predicts a poor response to paclitaxel in patients with triple-negative breast cancer.

about

OTUD7B upregulation predicts a poor response to paclitaxel in patients with triple-negative breast cancer.

Item

http://www.wikidata.org/entity/Q49489812

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

OTUD7B upregulation predicts a ...... triple-negative breast cancer.

@en

OTUD7B upregulation predicts a ...... triple-negative breast cancer.

@nl

type

Item

label

OTUD7B upregulation predicts a ...... triple-negative breast cancer.

@en

OTUD7B upregulation predicts a ...... triple-negative breast cancer.

@nl

prefLabel

OTUD7B upregulation predicts a ...... triple-negative breast cancer.

@en

OTUD7B upregulation predicts a ...... triple-negative breast cancer.

@nl

P1476

OTUD7B upregulation predicts a ...... triple-negative breast cancer.

@en

P2093

Hui-Wen Chiu

http://www.w3.org/2001/XMLSchema#string

Hui-Yu Lin

http://www.w3.org/2001/XMLSchema#string

Ing-Jy Tseng

http://www.w3.org/2001/XMLSchema#string

Yuan-Feng Lin

http://www.w3.org/2001/XMLSchema#string

P2860

OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis

Selective blockade of microRNA processing by Lin28

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

OTUB1 Co-opts Lys48-Linked Ubiquitin Recognition to Suppress E2 Enzyme Function

The mechanism of OTUB1-mediated inhibition of ubiquitination

Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer

Elevated expression of Nrf2 mediates multidrug resistance in CD133(+) head and neck squamous cell carcinoma stem cells

OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3

Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells

NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells

P304

553-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23074

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416635

http://www.w3.org/2001/XMLSchema#string

P932

5787489

http://www.w3.org/2001/XMLSchema#string